BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16282089)

  • 1. Pharmacotherapy treatment in substance-dependent correctional populations: a review.
    Cropsey KL; Villalobos GC; St Clair CL
    Subst Use Misuse; 2005; 40(13-14):1983-99, 2043-8. PubMed ID: 16282089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological treatment of substance dependence from a neuroscientific perspective (I): opiates and cocaine].
    Haro G; Cervera G; Martínez-Raga J; Pérez-Gálvez B; Fernández-Garcés M; Sanjuan J
    Actas Esp Psiquiatr; 2003; 31(4):205-19. PubMed ID: 12838444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating drug treatment needs among state prison inmates.
    Belenko S; Peugh J
    Drug Alcohol Depend; 2005 Mar; 77(3):269-81. PubMed ID: 15734227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of addictions.
    Kreek MJ; LaForge KS; Butelman E
    Nat Rev Drug Discov; 2002 Sep; 1(9):710-26. PubMed ID: 12209151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insufficient information in drug-related hospital morbidity study.
    Newman RG
    Arch Gen Psychiatry; 2009 Mar; 66(3):331; author reply 331-2. PubMed ID: 19255384
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating incarcerated women: gender matters.
    Lewis C
    Psychiatr Clin North Am; 2006 Sep; 29(3):773-89. PubMed ID: 16904511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regarding naltrexone for probationers and parolees.
    Stancliff S
    J Subst Abuse Treat; 2007 Mar; 32(2):217-8; author reply 218-9. PubMed ID: 17306730
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone in patients with bipolar disorder and alcohol dependence.
    Brown ES; Beard L; Dobbs L; Rush AJ
    Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug use and health among prison inmates.
    Kanato M
    Curr Opin Psychiatry; 2008 May; 21(3):252-4. PubMed ID: 18382223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada.
    Johnson S; MacDonald SF; Cheverie M; Myrick C; Fischer B
    Drug Alcohol Depend; 2012 Jul; 124(1-2):172-6. PubMed ID: 22265193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What works in substance misuse treatments for offenders?
    McMurran M
    Crim Behav Ment Health; 2007; 17(4):225-33. PubMed ID: 17902119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.
    Colker AC
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-6. PubMed ID: 12875273
    [No Abstract]   [Full Text] [Related]  

  • 14. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico.
    Heimer R; Catania H; Newman RG; Zambrano J; Brunet A; Ortiz AM
    Drug Alcohol Depend; 2006 Jun; 83(2):122-9. PubMed ID: 16332415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
    Tait RJ; Ngo HT; Hulse GK
    J Subst Abuse Treat; 2008 Sep; 35(2):116-24. PubMed ID: 17931824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment needs and completion of community-based aftercare among substance-abusing women offenders.
    Grella CE; Greenwell L
    Womens Health Issues; 2007; 17(4):244-55. PubMed ID: 17544296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?
    Larney S; Dolan K
    Eur Addict Res; 2009; 15(2):107-12. PubMed ID: 19182485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for the opioid addict: agonists or antagonists?
    Ketchum JS; Jarvik ME
    Ration Drug Ther; 1979 Jan; 13(1):1-5. PubMed ID: 451229
    [No Abstract]   [Full Text] [Related]  

  • 19. Safe approaches to treating drug addiction.
    Keaney F; Farrell M
    Practitioner; 2000 May; 244(1610):410, 414-6, 418-20 passim. PubMed ID: 10962832
    [No Abstract]   [Full Text] [Related]  

  • 20. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.